Exponentiation In Innovation To Drive The Human Insulin Market - PowerPoint PPT Presentation

About This Presentation
Title:

Exponentiation In Innovation To Drive The Human Insulin Market

Description:

The global human insulin market was anticipated to grow from an estimated USD 24,332.6 million in 2014 to USD 49,197.3 million in 2020 at a CAGR of 12.4% during the forecast period. – PowerPoint PPT presentation

Number of Views:50

less

Transcript and Presenter's Notes

Title: Exponentiation In Innovation To Drive The Human Insulin Market


1
Human Insulin Market
Report Id PMRREP3308 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas


Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Exponentiation In Innovation To Drive The Human
Insulin Market
  • According to a new market report published by
    Persistence Market Research Global Market Study
    on Human Insulin Asia Pacific to Witness fastest
    Growth by 2020, the global human insulin market
    was valued at USD 24,332.6 million in 2014 and
    was expected to grow at a CAGR of 12.4 from 2014
    to 2020, to reach an estimated value of USD
    49,197.3 million in 2020.
  • Globally, the human insulin market is witnessing
    significant growth due to increasing prevalence
    of diabetes and increasing awareness among people
    about diabetes care. In addition, technological
    advancements in insulin delivery devices and
    increasing prevalence of lifestyle related
    disorders such as obesity are also driving the
    growth of the market. However, uneven pricing and
    limited access to human insulin in emerging
    countries such as Brazil, India, and China are
    inhibiting the growth of the human insulin
    market. In addition, strict regulatory
    requirements for drug approval are also
    restraining the growth of the market. The global
    human insulin market was anticipated to grow from
    an estimated USD 24,332.6 million in 2014 to USD
    49,197.3 million in 2020 at a CAGR of 12.4
    during the forecast period.

Get Sample Copy of this Report_at_
https//www.persistencemarketresearch.com/samples/
3308
4
Key Trends
  • In North America, increasing prevalence of
    diabetes with growing age and availability of
    advanced human insulin infusion devices are
    driving the use of human insulin in the market. 
  • In Europe, the human insulin market is driven by
    rising aging population and increasing prevalence
    of diabetes. In addition, in Germany the market
    is evolving due to rising prevalence of diabetes
    and increasing awareness among people about
    diabetes care. However, in Asia-Pacific the
    growth for human insulin is much higher than
    developed countries due to increasing prevalence
    of diabetes and increasing government initiatives
    for improving healthcare.
  • Novo Nordisk A/S, Eli Lilly and Company, Sanofi,
    Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd.,
    Adocia, Merck Co., Inc., Pfizer, Inc.,
    Wockhardt, Julphar, Bristol-Myers Squibb Company,
    GlaxoSmithKline Plc and Oramed Pharmaceuticals,
    Inc. are some of the major players in human
    insulin market.

Access Full Report_at_ https//www.persistencemarketr
esearch.com/checkout/3308
5
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com